Harshad R. Kulkarni, MD
BAMF Health
Grand Rapids, Michigan
Harshad R. Kulkarni, MD, is Chief Medical Advisor at BAMF Health in Grand Rapids, Michigan. An internationally recognized physician-scientist in nuclear medicine and theranostics, he focuses on translating advanced molecular imaging and radiopharmaceutical therapy into precise, individualized cancer care.
Before joining BAMF Health, Dr. Kulkarni spent more than a decade at the Theranostics Center for Molecular Radiotherapy and Precision Oncology at Zentralklinik Bad Berka, Germany. There, he contributed to the care of patients across more than 10,000 radiomolecular therapy administrations and helped advance the early clinical use of PSMA-targeted radioligand therapy. He completed postgraduate training in Medical Nuclide Techniques at Uppsala University and specialist training in nuclear medicine in Germany.
At BAMF Health, he provides scientific and clinical leadership across radiopharmaceutical therapy, total-body PET/CT, PET/MR, quantitative SPECT/CT, dosimetry, and clinical trials. His research spans prostate cancer, neuroendocrine tumors, FAP-targeted imaging and therapy, novel radiopharmaceuticals, and AI-enabled precision theranostics. Dr. Kulkarni has authored more than 100 scientific publications and serves on international scientific and industry advisory boards, helping shape the responsible development and implementation of next-generation theranostics.
Disclosures:
- Employment: BAMF Health:Chief Medical Advisor:Employee
- Compensation: :Role Topic Description-End Date:
- Ownership: none
- Leadership: none